Beta — please read before use

Vessel Ref is an experimental beta tool

Responses are generated by an AI model and are derived solely from the referenced source categories (Gore Vascular/Endovascular Surgery Training Manual; SVS guidelines; ESVS guidelines; AHA/ACC guidelines; CHEST / multi-society VTE & PE guidelines; and other listed reference categories), plus live web search of those sources. Outputs may still be incomplete, out of date, or mistaken — the underlying sources themselves are not always in full consensus, and the tool has not been independently validated as a clinical decision support device.

This tool does not provide medical advice, does not replace clinical judgment, attending oversight, institutional protocol, or the primary literature, and is not intended to direct care for any specific patient. Nothing generated here should be treated as validated or final without independent verification.

By continuing, you acknowledge this is a beta tool provided for educational/reference orientation only, used at your own discretion and professional judgment.

Vessel Ref

Vascular Clinical Reference

Reference library

01 Gore Vascular/Endovascular Surgery Training Manual 3rd ed. — formerly the "Combat Manual"
02 SVS Guidelines Society for Vascular Surgery practice guidelines, incl. SVS/ERAS Society perioperative consensus statements (open aortic, infrainguinal bypass, major limb amputation)
03 ESVS Guidelines European Society for Vascular Surgery
04 AHA / ACC Guidelines American Heart Association / College of Cardiology
05 Landmark trials CREST-2, BASIL-2, BEST-CLI
06 EVAR endograft IFU & outcomes Gore, Medtronic, Cook, Endologix (AFX/AFX2/Alto), Bolton/Terumo Aortic
07 TEVAR & branched/fenestrated IFU & outcomes Gore TAG/TBE/TAMBE/IBE, Medtronic Valiant, Cook Zenith Alpha Thoracic/t-Branch/ZFEN/ZBIS, Terumo RelayPro/RelayBranch — approval status noted per device
08 KDOQI Guidelines National Kidney Foundation — Clinical Practice Guideline for Vascular Access (dialysis access workup, creation, surveillance)
09 SVS/AVF Venous Guidelines Joint SVS, American Venous Forum & American Vein and Lymphatic Society guidelines — varicose veins, chronic venous disease
10 CHEST / Multi-society VTE & PE Guidelines CHEST 2021 antithrombotic therapy guideline (VTE/DVT/PE treatment & duration); 2026 AHA/ACC-led multi-society guideline for evaluation & management of acute PE — attributed separately by actual authorship
11 EVToday Device Guide Endovascular Today's live, industry-compiled directory (guidewires, peripheral/PAD stents & balloons, embolic devices, IVC filters, atherectomy, closure, dialysis access devices) — secondary trade reference, not a guideline or primary FDA document

Scope. Answers are paraphrased and cited, never reproduced verbatim from source text. Trials (05) and device IFU/outcomes data (06, 07) are individual studies or manufacturer documents, not consensus guidelines — flagged as such when they conflict with or pre-date current society guidance. For category 07 specifically, FDA approval status varies by device — some are fully approved, some investigational-only (IDE/feasibility) — and the app states this explicitly rather than implying availability. KDOQI (08) is a National Kidney Foundation guideline, not a vascular surgery society document — included because SVS defers to it for dialysis access decisions. Category 09 documents are joint publications; the American Venous Forum notes it did not create or endorse the original 2011 guideline, so the app attributes authorship precisely rather than as "AVF guidelines." Category 10 covers two distinct documents rather than a single "CHEST guideline": the 2021 CHEST antithrombotic VTE guideline is CHEST's own, while the 2026 acute PE guideline is a ten-society document led by the ACC/AHA Joint Committee on Clinical Practice Guidelines with CHEST as one co-sponsor among many — the app attributes each by its actual authorship rather than shorthanding both as "CHEST." Category 11 (EVToday Device Guide) is a live, industry-maintained web directory of manufacturer-submitted device specs, not a peer-reviewed guideline or FDA document — the app treats it as secondary and defers to a device's own IFU or FDA status when the two conflict. Built for quick orientation — confirm against the primary source before acting on it.

Ask a vascular question

live search

Built for the floor, the clinic, and the reading room

Ask what you'd ask on rounds — ABI thresholds, EVAR surveillance intervals, DAPT duration after carotid stenting, heparin reversal dosing. Every answer is grounded and sourced.

Beta tool. Responses are AI-generated and derived solely from the referenced source categories (Gore manual; SVS, ESVS, AHA/ACC guidelines; CHEST / multi-society VTE & PE guidelines; and other listed reference categories) plus live web search of those sources — they are not independently verified clinical advice and may be incomplete, out of date, or mistaken. Not a substitute for clinical judgment, institutional protocol, attending oversight, or the primary literature. Not intended to direct care for any specific patient. Verify anything before it changes patient management.